World journal of stem cells最新文献

{"title":"Clinical application prospects and transformation value of dental follicle stem cells in oral and neurological diseases.","authors":"Chao Yang,&nbsp;Xin-Ya Du,&nbsp;Wen Luo","doi":"10.4252/wjsc.v15.i4.136","DOIUrl":"https://doi.org/10.4252/wjsc.v15.i4.136","url":null,"abstract":"<p><p>Since dental pulp stem cells (DPSCs) were first reported, six types of dental SCs (DSCs) have been isolated and identified. DSCs originating from the craniofacial neural crest exhibit dental-like tissue differentiation potential and neuro-ectodermal features. As a member of DSCs, dental follicle SCs (DFSCs) are the only cell type obtained at the early developing stage of the tooth prior to eruption. Dental follicle tissue has the distinct advantage of large tissue volume compared with other dental tissues, which is a prerequisite for obtaining a sufficient number of cells to meet the needs of clinical applications. Furthermore, DFSCs exhibit a significantly higher cell proliferation rate, higher colony-formation capacity, and more primitive and better anti-inflammatory effects than other DSCs. In this respect, DFSCs have the potential to be of great clinical significance and translational value in oral and neurological diseases, with natural advantages based on their origin. Lastly, cryopreservation preserves the biological properties of DFSCs and enables them to be used as off-shelf products for clinical applications. This review summarizes and comments on the properties, application potential, and clinical transformation value of DFSCs, thereby inspiring novel perspectives in the future treatment of oral and neurological diseases.</p>","PeriodicalId":23775,"journal":{"name":"World journal of stem cells","volume":"15 4","pages":"136-149"},"PeriodicalIF":4.1,"publicationDate":"2023-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/70/d6/WJSC-15-136.PMC10173814.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9470345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Human pluripotent stem cell-derived β cells: Truly immature islet β cells for type 1 diabetes therapy?","authors":"Helen Jiang,&nbsp;Fang-Xu Jiang","doi":"10.4252/wjsc.v15.i4.182","DOIUrl":"https://doi.org/10.4252/wjsc.v15.i4.182","url":null,"abstract":"<p><p>A century has passed since the Nobel Prize winning discovery of insulin, which still remains the mainstay treatment for type 1 diabetes mellitus (T1DM) to this day. True to the words of its discoverer Sir Frederick Banting, \"insulin is not a cure for diabetes, it is a treatment\", millions of people with T1DM are dependent on daily insulin medications for life. Clinical donor islet transplantation has proven that T1DM is curable, however due to profound shortages of donor islets, it is not a mainstream treatment option for T1DM. Human pluripotent stem cell derived insulin-secreting cells, pervasively known as stem cell-derived β cells (SC-β cells), are a promising alternative source and have the potential to become a T1DM treatment through cell replacement therapy. Here we briefly review how islet β cells develop and mature <i>in vivo</i> and several types of reported SC-β cells produced using different <i>ex vivo</i> protocols in the last decade. Although some markers of maturation were expressed and glucose stimulated insulin secretion was shown, the SC-β cells have not been directly compared to their <i>in vivo</i> counterparts, generally have limited glucose response, and are not yet fully matured. Due to the presence of extra-pancreatic insulin-expressing cells, and ethical and technological issues, further clarification of the true nature of these SC-β cells is required.</p>","PeriodicalId":23775,"journal":{"name":"World journal of stem cells","volume":"15 4","pages":"182-195"},"PeriodicalIF":4.1,"publicationDate":"2023-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/92/e3/WJSC-15-182.PMC10173812.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9470350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Obesity and cancer stem cells: Roles in cancer initiation, progression and therapy resistance.","authors":"Wen-Jie Xie,&nbsp;Jian Li","doi":"10.4252/wjsc.v15.i4.120","DOIUrl":"https://doi.org/10.4252/wjsc.v15.i4.120","url":null,"abstract":"<p><p>Obesity, the global pandemic since industrialization, is the number one lifestyle-related risk factor for premature death, which increases the incidence and mortality of various diseases and conditions, including cancer. In recent years, the theory of cancer stem cells (CSCs), which have the capacity for self-renewal, metastasis and treatment resistance, has been bolstered by increasing evidence. However, research on how obesity affects CSCs to facilitate cancer initiation, progression and therapy resistance is still in its infancy, although evidence has already begun to accumulate. Regarding the ever-increasing burden of obesity and obesity-related cancer, it is pertinent to summarize evidence about the effects of obesity on CSCs, as elucidating these effects will contribute to the improvement in the management of obesity-related cancers. In this review, we discuss the association between obesity and CSCs, with a particular focus on how obesity promotes cancer initiation, progression and therapy resistance through CSCs and the mechanisms underlying these effects. In addition, the prospect of preventing cancer and targeting the mechanisms linking obesity and CSCs to reduce cancer risk or to improve the survival of patients with cancer is considered.</p>","PeriodicalId":23775,"journal":{"name":"World journal of stem cells","volume":"15 4","pages":"120-135"},"PeriodicalIF":4.1,"publicationDate":"2023-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d8/98/WJSC-15-120.PMC10173809.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9468165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Repetitive administration of cultured human CD34+ cells improve adenine-induced kidney injury in mice.","authors":"Takayasu Ohtake,&nbsp;Shoichi Itaba,&nbsp;Amankeldi A Salybekov,&nbsp;Yin Sheng,&nbsp;Tsutomu Sato,&nbsp;Mitsuru Yanai,&nbsp;Makoto Imagawa,&nbsp;Shigeo Fujii,&nbsp;Hiroki Kumagai,&nbsp;Masamitsu Harata,&nbsp;Takayuki Asahara,&nbsp;Shuzo Kobayashi","doi":"10.4252/wjsc.v15.i4.268","DOIUrl":"https://doi.org/10.4252/wjsc.v15.i4.268","url":null,"abstract":"<p><strong>Background: </strong>There is no established treatment to impede the progression or restore kidney function in human chronic kidney disease (CKD).</p><p><strong>Aim: </strong>To examine the efficacy of cultured human CD34+ cells with enhanced proliferating potential in kidney injury in mice.</p><p><strong>Methods: </strong>Human umbilical cord blood (UCB)-derived CD34+ cells were incubated for one week in vasculogenic conditioning medium. Vasculogenic culture significantly increased the number of CD34+ cells and their ability to form endothelial progenitor cell colony-forming units. Adenine-induced tubulointerstitial injury of the kidney was induced in immunodeficient non-obese diabetic/severe combined immunodeficiency mice, and cultured human UCB-CD34+ cells were administered at a dose of 1 × 10⁶/mouse on days 7, 14, and 21 after the start of adenine diet.</p><p><strong>Results: </strong>Repetitive administration of cultured UCB-CD34+ cells significantly improved the time-course of kidney dysfunction in the cell therapy group compared with that in the control group. Both interstitial fibrosis and tubular damage were significantly reduced in the cell therapy group compared with those in the control group (<i>P</i> < 0.01). Microvasculature integrity was significantly preserved (<i>P</i> < 0.01) and macrophage infiltration into kidney tissue was dramatically decreased in the cell therapy group compared with those in the control group (<i>P</i> < 0.001).</p><p><strong>Conclusion: </strong>Early intervention using human cultured CD34+ cells significantly improved the progression of tubulointerstitial kidney injury. Repetitive administration of cultured human UCB-CD34+ cells significantly improved tubulointerstitial damage in adenine-induced kidney injury in mice <i>via</i> vasculoprotective and anti-inflammatory effects.</p>","PeriodicalId":23775,"journal":{"name":"World journal of stem cells","volume":"15 4","pages":"268-280"},"PeriodicalIF":4.1,"publicationDate":"2023-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8a/2b/WJSC-15-268.PMC10173816.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9473465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Bone marrow mesenchymal stem cell-derived exosomal microRNAs target PI3K/Akt signaling pathway to promote the activation of fibroblasts.","authors":"Fang-Qi Li,&nbsp;Wen-Bo Chen,&nbsp;Zhi-Wen Luo,&nbsp;Yi-Sheng Chen,&nbsp;Ya-Ying Sun,&nbsp;Xiao-Ping Su,&nbsp;Jun-Ming Sun,&nbsp;Shi-Yi Chen","doi":"10.4252/wjsc.v15.i4.248","DOIUrl":"https://doi.org/10.4252/wjsc.v15.i4.248","url":null,"abstract":"<p><strong>Background: </strong>Fibroblast plays a major role in tendon-bone healing. Exosomes derived from bone marrow mesenchymal stem cells (BMSCs) can activate fibroblasts and promote tendon-bone healing <i>via</i> the contained microRNAs (miRNAs). However, the underlying mechanism is not comprehensively understood. Herein, this study aimed to identify overlapped BMSC-derived exosomal miRNAs in three GSE datasets, and to verify their effects as well as mechanisms on fibroblasts.</p><p><strong>Aim: </strong>To identify overlapped BMSC-derived exosomal miRNAs in three GSE datasets and verify their effects as well as mechanisms on fibroblasts.</p><p><strong>Methods: </strong>BMSC-derived exosomal miRNAs data (GSE71241, GSE153752, and GSE85341) were downloaded from the Gene Expression Omnibus (GEO) database. The candidate miRNAs were obtained by the intersection of three data sets. TargetScan was used to predict potential target genes for the candidate miRNAs. Functional and pathway analyses were conducted using the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases, respectively, by processing data with the Metascape. Highly interconnected genes in the protein-protein interaction (PPI) network were analyzed using Cytoscape software. Bromodeoxyuridine, wound healing assay, collagen contraction assay and the expression of COL I and α-smooth muscle actin positive were applied to investigate the cell proliferation, migration and collagen synthesis. Quantitative real-time reverse transcription polymerase chain reaction was applied to determine the cell fibroblastic, tenogenic, and chondrogenic potential.</p><p><strong>Results: </strong>Bioinformatics analyses found two BMSC-derived exosomal miRNAs, has-miR-144-3p and has-miR-23b-3p, were overlapped in three GSE datasets. PPI network analysis and functional enrichment analyses in the GO and KEGG databases indicated that both miRNAs regulated the PI3K/Akt signaling pathway by targeting phosphatase and tensin homolog (PTEN). <i>In vitro</i> experiments confirmed that miR-144-3p and miR-23b-3p stimulated proliferation, migration and collagen synthesis of NIH3T3 fibroblasts. Interfering with PTEN affected the phosphorylation of Akt and thus activated fibroblasts. Inhibition of PTEN also promoted the fibroblastic, tenogenic, and chondrogenic potential of NIH3T3 fibroblasts.</p><p><strong>Conclusion: </strong>BMSC-derived exosomes promote fibroblast activation possibly through the PTEN and PI3K/Akt signaling pathways, which may serve as potential targets to further promote tendon-bone healing.</p>","PeriodicalId":23775,"journal":{"name":"World journal of stem cells","volume":"15 4","pages":"248-267"},"PeriodicalIF":4.1,"publicationDate":"2023-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c7/60/WJSC-15-248.PMC10173806.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9470351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Extracellular vesicles: Emerged as a promising strategy for regenerative medicine.","authors":"Dian-Ri Wang,&nbsp;Jian Pan","doi":"10.4252/wjsc.v15.i4.165","DOIUrl":"https://doi.org/10.4252/wjsc.v15.i4.165","url":null,"abstract":"<p><p>Cell transplantation therapy has certain limitations including immune rejection and limited cell viability, which seriously hinder the transformation of stem cell-based tissue regeneration into clinical practice. Extracellular vesicles (EVs) not only possess the advantages of its derived cells, but also can avoid the risks of cell transplantation. EVs are intelligent and controllable biomaterials that can participate in a variety of physiological and pathological activities, tissue repair and regeneration by transmitting a variety of biological signals, showing great potential in cell-free tissue regeneration. In this review, we summarized the origins and characteristics of EVs, introduced the pivotal role of EVs in diverse tissues regeneration, discussed the underlying mechanisms, prospects, and challenges of EVs. We also pointed out the problems that need to be solved, application directions, and prospects of EVs in the future and shed new light on the novel cell-free strategy for using EVs in the field of regenerative medicine.</p>","PeriodicalId":23775,"journal":{"name":"World journal of stem cells","volume":"15 4","pages":"165-181"},"PeriodicalIF":4.1,"publicationDate":"2023-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/88/4a/WJSC-15-165.PMC10173817.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9473467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Roles of cancer stem cells in gastrointestinal cancers.","authors":"Shi-Hai Xuan,&nbsp;Meng-Lu Hua,&nbsp;Ze Xiang,&nbsp;Xiang-Lin He,&nbsp;Lan Huang,&nbsp;Chun Jiang,&nbsp;Peng Dong,&nbsp;Jian Wu","doi":"10.4252/wjsc.v15.i4.209","DOIUrl":"https://doi.org/10.4252/wjsc.v15.i4.209","url":null,"abstract":"<p><p>Cancer stem cells (CSCs) are the main cause of tumor growth, invasion, metastasis and recurrence. Recently, CSCs have been extensively studied to identify CSC-specific surface markers as well as signaling pathways that play key roles in CSCs self-renewal. The involvement of CSCs in the pathogenesis of gastrointestinal (GI) cancers also highlights these cells as a priority target for therapy. The diagnosis, prognosis and treatment of GI cancer have always been a focus of attention. Therefore, the potential application of CSCs in GI cancers is receiving increasing attention. This review summarizes the role of CSCs in GI cancers, focusing on esophageal cancer, gastric cancer, liver cancer, colorectal cancer, and pancreatic cancer. In addition, we propose CSCs as potential targets and therapeutic strategies for the effective treatment of GI cancers, which may provide better guidance for clinical treatment of GI cancers.</p>","PeriodicalId":23775,"journal":{"name":"World journal of stem cells","volume":"15 4","pages":"209-220"},"PeriodicalIF":4.1,"publicationDate":"2023-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d9/5d/WJSC-15-209.PMC10173810.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9473468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Current status and prospects of basic research and clinical application of mesenchymal stem cells in acute respiratory distress syndrome.","authors":"Tian-Yu Liang,&nbsp;Li-Hai Lu,&nbsp;Si-Yu Tang,&nbsp;Zi-Hao Zheng,&nbsp;Kai Shi,&nbsp;Jing-Quan Liu","doi":"10.4252/wjsc.v15.i4.150","DOIUrl":"https://doi.org/10.4252/wjsc.v15.i4.150","url":null,"abstract":"<p><p>Acute respiratory distress syndrome (ARDS) is a common and clinically devastating disease that causes respiratory failure. Morbidity and mortality of patients in intensive care units are stubbornly high, and various complications severely affect the quality of life of survivors. The pathophysiology of ARDS includes increased alveolar-capillary membrane permeability, an influx of protein-rich pulmonary edema fluid, and surfactant dysfunction leading to severe hypoxemia. At present, the main treatment for ARDS is mechanical treatment combined with diuretics to reduce pulmonary edema, which primarily improves symptoms, but the prognosis of patients with ARDS is still very poor. Mesenchymal stem cells (MSCs) are stromal cells that possess the capacity to self-renew and also exhibit multilineage differentiation. MSCs can be isolated from a variety of tissues, such as the umbilical cord, endometrial polyps, menstrual blood, bone marrow, and adipose tissues. Studies have confirmed the critical healing and immunomodulatory properties of MSCs in the treatment of a variety of diseases. Recently, the potential of stem cells in treating ARDS has been explored <i>via</i> basic research and clinical trials. The efficacy of MSCs has been shown in a variety of <i>in vivo</i> models of ARDS, reducing bacterial pneumonia and ischemia-reperfusion injury while promoting the repair of ventilator-induced lung injury. This article reviews the current basic research findings and clinical applications of MSCs in the treatment of ARDS in order to emphasize the clinical prospects of MSCs.</p>","PeriodicalId":23775,"journal":{"name":"World journal of stem cells","volume":"15 4","pages":"150-164"},"PeriodicalIF":4.1,"publicationDate":"2023-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4d/cc/WJSC-15-150.PMC10173811.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10645345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Role of brahma-related gene 1/brahma-associated factor subunits in neural stem/progenitor cells and related neural developmental disorders.","authors":"Nai-Yu Ke, Tian-Yi Zhao, Wan-Rong Wang, Yu-Tong Qian, Chao Liu","doi":"10.4252/wjsc.v15.i4.235","DOIUrl":"10.4252/wjsc.v15.i4.235","url":null,"abstract":"<p><p>Different fates of neural stem/progenitor cells (NSPCs) and their progeny are determined by the gene regulatory network, where a chromatin-remodeling complex affects synergy with other regulators. Here, we review recent research progress indicating that the BRG1/BRM-associated factor (BAF) complex plays an important role in NSPCs during neural development and neural developmental disorders. Several studies based on animal models have shown that mutations in the BAF complex may cause abnormal neural differentiation, which can also lead to various diseases in humans. We discussed BAF complex subunits and their main characteristics in NSPCs. With advances in studies of human pluripotent stem cells and the feasibility of driving their differentiation into NSPCs, we can now investigate the role of the BAF complex in regulating the balance between self-renewal and differentiation of NSPCs. Considering recent progress in these research areas, we suggest that three approaches should be used in investigations in the near future. Sequencing of whole human exome and genome-wide association studies suggest that mutations in the subunits of the BAF complex are related to neurodevelopmental disorders. More insight into the mechanism of BAF complex regulation in NSPCs during neural cell fate decisions and neurodevelopment may help in exploiting new methods for clinical applications.</p>","PeriodicalId":23775,"journal":{"name":"World journal of stem cells","volume":"15 4","pages":"235-247"},"PeriodicalIF":3.6,"publicationDate":"2023-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f6/b9/WJSC-15-235.PMC10173807.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9473466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Harnessing and honing mesenchymal stem/stromal cells for the amelioration of graft-versus-host disease.","authors":"Tang-Her Jaing,&nbsp;Tsung-Yen Chang,&nbsp;Chia-Chi Chiu","doi":"10.4252/wjsc.v15.i4.221","DOIUrl":"https://doi.org/10.4252/wjsc.v15.i4.221","url":null,"abstract":"<p><p>Allogeneic hematopoietic stem cell transplantation is a deterministic curative procedure for various hematologic disorders and congenital immunodeficiency. Despite its increased use, the mortality rate for patients undergoing this procedure remains high, mainly due to the perceived risk of exacerbating graft-versus-host disease (GVHD). However, even with immunosuppressive agents, some patients still develop GVHD. Advanced mesenchymal stem/stromal cell (MSC) strategies have been proposed to achieve better therapeutic outcomes, given their immunosuppressive potential. However, the efficacy and trial designs have varied among the studies, and some research findings appear contradictory due to the challenges in characterizing the <i>in vivo</i> effects of MSCs. This review aims to provide real insights into this clinical entity, emphasizing diagnostic, and therapeutic considerations and generating pathophysiology hypotheses to identify research avenues. The indications and timing for the clinical application of MSCs are still subject to debate.</p>","PeriodicalId":23775,"journal":{"name":"World journal of stem cells","volume":"15 4","pages":"221-234"},"PeriodicalIF":4.1,"publicationDate":"2023-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/16/25/WJSC-15-221.PMC10173808.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9470346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}